非小细胞肺癌的进展与ROS1重组
Xin Yang1, Zhe Tang2, Jing Li1
1Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Frontiers in molecular biosciences
|January 8, 2024
概括
在非小细胞肺癌 (NSCLC) 中发生ROS1重组,并且可以通过氨酸激酶抑制剂 (TKI) 准. 本综述涵盖了NSCLC患者的ROS1瘤原性,检测和抵抗机制.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在0.9%-2.6%的非小细胞肺癌 (NSCLC) 病例中发现了ROS1重组.
- 针对ROS1的氨酸激酶抑制剂 (TKI) 显示出阻断瘤生长和改善患者结果的有效性.
研究的目的:
- 提供关于NSCLC中ROS1重排的当前知识的全面审查.
- 阐明与ROS1阳性NSCLC相关的致癌机制,流行病学,检测,分子特征,疗法和耐药性模式.
主要方法:
- 关于NSCLC中ROS1重组研究的文献综述.
- 综合有关瘤致癌途径,诊断方法和临床数据的信息.
主要成果:
- 通过各种机制,ROS1重组驱动瘤发生.
- 存在各种方法来检测ROS1重组,影响治疗选择.
- 了解分子特征和抵抗机制对于有效的TKI治疗至关重要.
结论:
- 在NSCLC中,ROS1的重新排列是一个重要的可操作的目标.
- 像TKIs这样的向疗法为ROS1阳性NSCLC患者提供临床益处.
- 对抗药性机制的持续研究将完善未来的治疗策略.
更多相关视频
10:35A Blood-based Test for the Detection of ROS1 and RET Fusion Transcripts from Circulating Ribonucleic Acid Using Digital Polymerase Chain Reaction
Published on: April 5, 2018
10.4K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.0K
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
The Retinoblastoma Gene
4.1K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.1K
